Horizon Discovery, UK's ICR in Cancer Target Screening Pact

The partners will perform genome-wide screens to look for weak spots in cancer cells that could be targeted by anti-cancer drugs.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.